Delivery Order SPE2DR25D2214-SPE2DR26FV8E2
- Not listed
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,748.98 on November 25, 2025, for the supply of Miebo 100% eye drops (3ml). The Defense Logistics Agency (DLA) issued this competitively awarded, firm fixed-price delivery order, which is scheduled for completion by November 26, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.82 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drop (3mL) on January 27, 2026, with an ultimate completion date of January 28, 2026. This non-set-aside competitive award is structured as a firm fixed-price delivery order and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $50,173.91 by the Defense Logistics Agency on January 30, 2026, for the supply of Miebo 100% eye drop in 3ml quantities. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 2, 2026. This delivery order...
- On January 29, 2026, the Defense Logistics Agency awarded a $38.8K delivery order to AmerisourceBergen Drug Corp for 3mL units of Miebo 100% eye drop solution. The contract, valued at $38,751.99 with a firm fixed-price structure, carries an ultimate completion date of January 30, 2026 and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside award, indicating the contract was competitively awarded through open competition. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,461.56 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drop solution (3mL) on January 20, 2026, with completion expected by January 21, 2026. The award was made on a non-set-aside, competitive basis under firm fixed-price terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $30,256.76 for MIEBO 100% eye drop supply (3ml units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,560.30 of MIEBO 100% eye drop solution in 3ml units on December 22, 2025, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,401.99 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price, competitively awarded contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,897.98 for Miebo 100% eye drop (3mL) under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on December 2, 2025, for MIEBO 100% eye drops (3ml) with a ceiling value of $5,338.41. This firm fixed-price delivery order represents a non-set-aside award issued under a competitive process. The contract has an ultimate completion date of December 3, 2025, and the place of performance is located in Conshohocken,...
- SPE2DR25D2214Indefinite Delivery Contract
- SPE2DR25D2214-SPE2DR26FV8E2Delivery Order
On February 2, 2026, the Defense Logistics Agency awarded a delivery order valued at $7,025.15 to AmerSourceBergen Drug Corp for the supply of Miebo 100% eye drop medication in 3ml quantities. This is a firm fixed-price, non-set-aside contract with a completion date of February 3, 2026, to be performed in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC serves as a global pharmaceutical supply vehicle supporting military healthcare programs and encompasses a broad range of pharmaceutical products, medical supplies, specialty medications, and generic drugs required by military treatment facilities and veterans' healthcare systems worldwide. AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant position in federal medical procurement through its competitive contracting performance. The company's federal contract portfolio demonstrates extensive experience delivering diverse pharmaceutical products across multiple therapeutic domains to the Department of Defense and related health agencies. This particular delivery order for ophthalmic medication reflects the company's ongoing role as a critical vendor in the federal supply chain, with the capability to fulfill specialized medical commodity requirements through structured, firm fixed-price transactions that range from modest values to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 2/1/26 |